You are right - I follow what you mean now. In any case, on what I glean from MT's recent comments, every chance the company will be sold before then given it is being primed for takeover and likely the acquirer will be the one taking the drug to market in 2026 if all goes according to plan.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-964
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.81M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.0¢ | $212.6K | 1.118M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7234 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 260069 | 3 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |